Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

BACKGROUND: Endostatin is a circulating endogenous angiogenesis inhibitor preventing neovascularization. Previous studies demonstrated the prognostic value of Endostatin among patients with heart failure with reduced ejection fraction (HFrEF). However, the role of Endostatin among patients with hear...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arq Bras Cardiol
Main Authors: Barroso, Michael Coll, Boehme, Philip, Kramer, Frank, Mondritzki, Thomas, Koehler, Till, Gülker, Jan-Erik, Karoff, Martin, Dinh, Wilfried
Formato: Artigo
Idioma:Inglês
Publicado em: Sociedade Brasileira de Cardiologia - SBC 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729781/
https://ncbi.nlm.nih.gov/pubmed/28977054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20170144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados